Also listed on Ganymed Pharmaceuticals AG, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 11, 2030 · High confidence
20-year base term ends Nov 11, 2030
Nov 11, 2010
Nov 11, 2030
Nov 8, 2016
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 11, 2010, when application PCT/EP2010/006888, the earliest non-provisional in its chain, was filed (this one was filed Aug 13, 2012) | Nov 11, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,321,842, US 9,718,886) | resolves to Nov 11, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 11, 2030 | High confidence |
Partial family
| Application PCT/EP2010/006888 | PCT application no patent term | no patent term |
| US 9,487,584 | this patent Nov 2030 | Nov 2030 |
| US 9,932,401 | In force Nov 2030 | Nov 2030 |
| US 10,745,477 | In force Nov 2030 | Nov 2030 |
| US 11,858,988 | In force Nov 2030 | Nov 2030 |
| Application 18/520,242 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 21, 2014 Reel 33579, frame 590 | Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael | Ganymed Pharmaceuticals AG | Assignment of Assignor's Interest |
| Aug 29, 2014 Reel 33663, frame 412 | Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael | Ganymed Pharmaceuticals AG; Johannes Gutenberg-Universitat Mainz | Corrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz. |
| Aug 29, 2014 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Ganymed Pharmaceuticals AG | Corrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz. |
| Aug 29, 2014 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Johannes Gutenberg-Universitat Mainz | Corrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz. |
| Jul 7, 2020 Reel 53135, frame 922 | Ganymed Pharmaceuticals AG | Ganymed Pharmaceuticals GmbH | Change of Name |
| Aug 4, 2025 Reel 71926, frame 811 | Ganymed Pharmaceuticals GmbH | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Nov 10, 2025 Reel 72847, frame 700 | Johannes Gutenberg-Universität Mainz | Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg Universität Mainz GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,321,842, US 9,718,886, ends no earlier than this term, so it caps nothing.